We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

79 hedge funds and large institutions have $235M invested in Syneron Medical Ltd in 2017 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less capital invested

Capital invested by funds: $257M → $235M (-$22.5M)

13% less funds holding

Funds holding: 91 → 79 (-12)

27% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 44

36% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 22

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
79
Holders Change
-12
Holders Change %
-13.19%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
32
Increased
14
Reduced
22
Closed
44
Calls
$429K
Puts
–
Net Calls
+$429K
Net Calls Change
-$28K

Top Buyers

Rank Fund Capital Flow
1
GLAM
Gardner Lewis Asset Management
Pennsylvania
+$18M
2
AA
AQR Arbitrage
Connecticut
+$16.2M
3
KPF
K2 Principal Fund
Ontario, Canada
+$12.1M
4
FTCM
First Trust Capital Management
Illinois
+$9.66M
5
SG Americas Securities
SG Americas Securities
New York
+$5.61M

Top Sellers

Rank Fund Capital Flow
1
NTC
North Tide Capital
Massachusetts
-$31.6M
2
SM
Senvest Management
New York
-$23.2M
3
DGI
Discovery Group I
Illinois
-$12.9M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$12.1M
5
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
-$8.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Coastland Capital
California
$2.13M +$2.13M +194,155 New
GF
27
Gabelli Funds
New York
$2.1M +$1.95M +178,100 +1,272%
LAM
28
Lapides Asset Management
Connecticut
$2.04M -$2.31M -210,600 -53%
Vanguard Group
29
Vanguard Group
Pennsylvania
$1.73M +$1.73M +158,000 New
GP
30
GLG Partners
United Kingdom
$1.57M +$1.57M +143,548 New
TA
31
Teton Advisors
New York
$1.42M +$316K +28,800 +28%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$1.39M -$530K -48,303 -28%
MC
33
Menta Capital
California
$1.29M +$59.1K +5,387 +5%
OAC
34
OMERS Administration Corp
Ontario, Canada
$1.27M +$1.27M +115,800 New
PCM
35
Prelude Capital Management
New York
$1.26M +$978K +89,195 +347%
OAM
36
Oxford Asset Management
United Kingdom
$1.21M +$1.21M +110,000 New
AL
37
Airain Ltd
Guernsey
$1.09M +$1.1M +100,000 New
GCIA
38
Gabelli & Co Investment Advisers
New York
$1.07M +$1.07M +97,775 New
KCP
39
Kenmare Capital Partners
New York
$991K -$3.27M -298,677 -77%
DCM
40
DAFNA Capital Management
California
$941K – – –
Goldman Sachs
41
Goldman Sachs
New York
$940K +$368K +33,594 +64%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$857K -$2.38M -216,706 -73%
VCM
43
Vivaldi Capital Management
Illinois
$852K +$853K +77,763 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$834K -$98.7K -9,000 -11%
State Street
45
State Street
Massachusetts
$803K – – –
GI
46
GAMCO Investors
Connecticut
$796K +$534K +48,700 +203%
HM
47
Harvest Management
New York
$767K +$768K +70,000 New
RA
48
Royce & Associates
New York
$758K – – –
KC
49
Kellner Capital
New York
$758K +$759K +69,200 New
CL
50
CSS LLC
Illinois
$753K +$754K +68,770 New
1
2
3 4 5

ELOS Hedge Fund Activity: Q2 2017 in Review

79 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2017, worth a combined $235M — down 8.7% from $257M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of ELOS and 32 opened new positions — a net loss of 12 holders — while 22 trimmed existing stakes and 14 added.

The largest buyer was Gardner Lewis Asset Management, opening a new position worth an estimated $18M. The largest seller was North Tide Capital, exiting entirely with an estimated $31.6M sold.

  • 79 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2017, down from 91 in Q1 2017.
  • Funds reported $235M of Syneron Medical Ltd stock for Q2 2017, down 8.7% quarter-over-quarter.
  • 32 funds opened new Syneron Medical Ltd positions in Q2 2017 and 44 closed out, a net change of -12 holders.
  • The largest Syneron Medical Ltd buyer in Q2 2017 was Gardner Lewis Asset Management, an estimated $18M added.
  • The largest Syneron Medical Ltd seller in Q2 2017 was North Tide Capital, an estimated $31.6M sold.

Based on aggregated 13F filings for Q2 2017.